Guillaume Bouguen

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

46h-index8.9kcitations354works1.92yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(226), Microscopic Colitis(124), Diverticular Disease and Complications(42), Anorectal Disease Treatments and Outcomes(37), Pelvic floor disorders treatments(36)

Publications345 total

P0457 A healthy diet is associated with sustained remission and low relapse rates in Inflammatory bowel disease: a prospective e-cohort study

Journal of Crohn s and Colitis·2026

P0663 Comparative Effectiveness of Advanced Therapies between Ulcerative Proctitis and More Extensive Forms of Ulcerative Colitis: Results from a Multicenter Real-World Study

Journal of Crohn s and Colitis·2026

P0489 Artificial Intelligence versus conventional scoring for assessing small bowel capsule endoscopy cleanliness in Crohn’s disease

Journal of Crohn s and Colitis·2026

P1071 Comparison of effectiveness between Vedolizumab and Filgotinib in patients with ulcerative colitis previously exposed to at least one anti-TNF agent: Results from the real-world evidence multicenter VEDOFIL study

Journal of Crohn s and Colitis·2026

DOP029 One-Year Effectiveness and Safety of Upadacitinib in 261 Patients With Crohn’s Disease: A Multicenter Real-World Cohort Study.

Journal of Crohn s and Colitis·2026Open Access

Diagnosis and management of patients with Crohn’s disease. Position paper from the GETAID

Clinics and Research in Hepatology and Gastroenterology·2025

Update on IBD management: What's new in acute severe UC? - Modern management of perianal disease

Clinics and Research in Hepatology and Gastroenterology·2025

Clinical Trial: Simplified Bowel Preparation for Small Bowel Capsule Endoscopy in Crohn's Disease

1 cited

Alimentary Pharmacology & Therapeutics·2025· 1 cited

CLONAL LYMPHOCYTE EXPANSIONS AND JAK-STAT PATHWAY MUTATIONS DEFINE A PATHOGENIC CONTINUUM DRIVING RESISTANCE TO GLUTEN-FREE DIET IN CELIAC DISEASE

2025Open Access

Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID

Journal of Crohn s and Colitis·2025

Real-world Comparison of the Effectiveness of Tofacitinib and Ustekinumab in Patients With Ulcerative Colitis: The TORUS Study

3 cited

Clinical Gastroenterology and Hepatology·2025· 3 cited

Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study

Journal of Crohn s and Colitis·2025

Discordance between patients’ perception and endoscopic assessment of disease activity in ulcerative colitis

Therapeutic Advances in Gastroenterology·2025Open Access

SEX DIFFERENCES ASSOCIATED WITH OVERALL TOLERANCE AFTER A SWITCH TO AN ADALIMUMAB BIOSIMILAR, A POST-HOC ANALYSIS FROM THE YU-MATTER STUDY

SPIRE - Sciences Po Institutional REpository·2025

ABS0695 SEX DIFFERENCES ASSOCIATED WITH OVERALL TOLERANCE AFTER A SWITCH TO AN ADALIMUMAB BIOSIMILAR, A POST-HOC ANALYSIS FROM THE YU-MATTER STUDY

Annals of the Rheumatic Diseases·2025Open Access

PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission

3 cited

Clinical Gastroenterology and Hepatology·2025· 3 citedOpen Access

912: COMPARATIVE EFFICACY OF INFLIXIMAB AND VEDOLIZUMAB AFTER FAILURE OF A FIRST ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS: A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL (EFFICACI)

Gastroenterology·2025

Tu1837: EFFECTIVENESS COMPARISONS BETWEEN TOFACITINIB, FILGOTINIB AND UPADACITINIB IN ULCERATIVE COLITIS: RESULTS FROM THE JAKARTA REAL-WORLD EVIDENCE MULTICENTER STUDY

Gastroenterology·2025

Tu1907: EVALUATION OF SUBCUTANEAOUS INFLIXIMAB FOR PERIANAL FISTULA HEALING IN CROHN’S DISEASE : PRELIMINARY RESULTS FROM THE REMSILAP MULTICENTER OBSERVATIONAL COHORT STUDY

Gastroenterology·2025

Endoscopic submucosal dissection for visible dysplasia in inflammatory bowel disease: a nationwide multicenter cohort from the GETAID and the SFED

3 cited

Journal of Crohn s and Colitis·2025· 3 cited

page 1 of 18Next →

Frequent Co-authors

Laurent Peyrin‐Biroulet(24), David Laharie(21), Mathurin Fuméry(19), Yoram Bouhnik(18), Véred Abitbol(17), Stéphane Nancey(17), Romain Altwegg(15), Aurélien Amiot(15), Stéphanie Viennot(14), Benjamin Pariente(13), Matthieu Allez(13), Xavier Roblin(13), Laurent Siproudhis(13), Guillaume Savoye(12), Anthony Buisson(11), Jérôme Filippi(11), Philippe Marteau(10), Anne Bourrier(10), Lucine Vuitton(10), Carmen Stefănescu(9)